当前位置:首页 - 行情中心 - 人福医药(600079) - 财务分析

人福医药

(600079)

  

流通市值:328.31亿  总市值:348.84亿
流通股本:15.36亿   总股本:16.32亿

人福医药(600079)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2023年年度实现净利润28.15亿元,每股收益1.32元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2023年年度最新股东权益2009861.21万元,未分配利润935725.14万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2023年年度最新总资产3620429.76万元,负债1610568.55万元。

利润表
报告期2023-12-312023-09-302023-06-302023-03-31
营业总收入24,524,740,572.6918,111,717,932.0412,382,998,383.936,225,735,090.21
营业总成本21,417,059,137.0815,716,222,804.2610,673,265,170.645,431,915,788.85
营业利润3,447,174,170.342,743,233,135.652,006,246,262.461,011,384,677.18
利润总额3,383,828,831.972,707,276,437.031,992,448,935.51,003,206,846.11
净利润2,815,265,811.72,283,150,716.381,690,687,483.37861,113,526.51
其他综合收益32,370,529.4788,219,201.6662,058,474.861,583,453.59
综合收益总额2,847,636,341.172,371,369,918.041,752,745,958.23862,696,980.1
资产负债表
报告期2023-12-312023-09-302023-06-302023-03-31
流动资产合计19,635,030,670.6720,199,989,726.8319,764,453,634.0618,573,673,268.13
非流动资产合计16,569,266,896.5216,508,434,916.0717,151,667,584.7516,843,573,193.68
资产总计36,204,297,567.1936,708,424,642.936,916,121,218.8135,417,246,461.81
流动负债合计13,225,866,187.1214,059,468,585.9615,003,193,271.0113,677,433,536.75
非流动负债合计2,879,819,274.593,029,721,6122,950,274,221.22,998,589,172.72
负债合计16,105,685,461.7117,089,190,197.9617,953,467,492.2116,676,022,709.47
归属于母公司股东权益合计17,043,599,963.3616,740,310,436.2916,204,944,570.8815,742,386,028.25
股东权益合计20,098,612,105.4819,619,234,444.9418,962,653,726.618,741,223,752.34
负债和股东权益合计36,204,297,567.1936,708,424,642.936,916,121,218.8135,417,246,461.81
现金流量表
报告期2023-12-312023-09-302023-06-302023-03-31
经营活动现金流入小计24,223,923,319.5217,265,475,023.611,447,358,681.035,145,179,609.39
经营活动现金流出小计22,256,673,594.3716,292,096,789.5211,062,439,613.325,663,257,165.43
经营活动产生的现金流量净额1,967,249,725.15973,378,234.08384,919,067.71-518,077,556.04
投资活动现金流入小计1,238,894,438.171,085,691,383.57306,124,018.98186,580,381.87
投资活动现金流出小计2,463,612,845.371,846,324,946.981,241,485,736.29404,212,954
投资活动产生的现金流量净额-1,224,718,407.2-760,633,563.41-935,361,717.31-217,632,572.13
筹资活动现金流入小计10,649,138,032.127,765,754,967.795,802,045,367.053,065,799,493.05
筹资活动现金流出小计12,754,705,473.218,668,188,602.626,418,851,200.523,788,735,176.06
筹资活动产生的现金流量净额-2,105,567,441.09-902,433,634.83-616,805,833.47-722,935,683.01
汇率变动对现金及现金等价物的影响16,299,425.1319,299,361.825,497,678.58-7,964,666.98
现金及现金等价物净增加额-1,346,736,698.01-670,389,602.36-1,141,750,804.49-1,466,610,478.16
期末现金及现金等价物余额2,990,444,543.173,666,791,638.823,195,430,436.692,870,570,763.02
最新报告期:2024-04-17
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
华创证券郑辰1.491.711.952024-04-17
浙商证券孙建,郭双喜1.521.752.012024-04-09
广发证券李安飞,罗佳荣1.541.852.222024-04-06
海通证券孟陆,余文心1.501.661.852024-04-03
开源证券余汝意1.511.872.222024-04-02
TOP↑